Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001096906-24-001849
Filing Date
2024-09-13
Accepted
2024-09-13 17:31:07
Documents
9
Effectiveness Date
2024-09-13

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES INC. - S-8 tpia_s8.htm S-8 45697
2 FILING FEE TABLE tpia_ex107.htm EX-FILING FEES 9116
3 MYCOTOPIA THERAPIES INC. 2024 EQUITY INCENTIVE PLAN tpia_ex4z5.htm EX-4.5 62171
4 OPINION OF JONATHAN D. LEINWAND, P.A. tpia_ex5z1.htm EX-5.1 4690
5 CONSENT OF FRUCI AND ASSOCIATES II LLP tpia_ex23z2.htm EX-23.2 2133
6 CONSENT OF PINNACLE tpia_ex23z3.htm EX-23.3 2475
7 IMAGE tpiaex5z1_1.jpg GRAPHIC 23025
8 IMAGE tpiaex23z2_1.jpg GRAPHIC 7873
9 IMAGE tpiaex23z2_2.jpg GRAPHIC 4983
  Complete submission text file 0001096906-24-001849.txt   177224
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282128 | Film No.: 241298805
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)